R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation

Sylvia Braselmann(Guy's Hospital), Vanessa Taylor(Guy's Hospital), H. Zhao(Guy's Hospital), Su Wang(Guy's Hospital), Catherine Sylvain(Guy's Hospital), Muhammad Baluom(Guy's Hospital), Kunbin Qu(Guy's Hospital), Ellen Herlaar(Guy's Hospital), Angela Lau(Guy's Hospital), Chi Young(Guy's Hospital), Brian Wong(Guy's Hospital), Scott Lovell(Guy's Hospital), Thomas Sun(Guy's Hospital), Gary Park(Guy's Hospital), Ankush B. Argade(Guy's Hospital), Stipo Jurčević(Guy's Hospital), Polly Pine(Guy's Hospital), Rajinder Singh(Guy's Hospital), Elliott B. Grossbard(Guy's Hospital), Donald G. Payan(Guy's Hospital), Esteban S. Masuda(Guy's Hospital)
Journal of Pharmacology and Experimental Therapeutics
September 1, 2006
Cited by 511

Abstract


Related Papers

No related papers found

Powered by citation graph analysis